News

May 4, 2016May 4, 2016

Galapagos, AbbVie Expand Collaboration on Cystic Fibrosis Treatments

Cystic Fibrosis, News

Galapagos NV and AbbVie are expanding their collaboration to continue their successful portfolio growth in cystic fibrosis (CF). The two companies are committed to increasing the potential milestones to Galapagos for Phase ... Read more

May 4, 2016May 4, 2016

Pulmonary Arterial Hypertension May Be Treatable with Inhaled Gene Therapy

News, Pulmonary Hypertension

Researchers managed to halt the progression of pulmonary arterial hypertension (PAH) using a specific gene therapy approach in a pig model of the disease. The findings mean that in the future, ... Read more

May 3, 2016May 3, 2016

FDA Grants 510(k) Clearance for Lung Cancer Screening to Philips’ Early Detection CT Solutions

Lung Cancer, News

Amsterdam-based Royal Philips recently announced that any hospital or healthcare facility with one of the company’s computed tomography (CT) models will now be eligible to become a lung cancer screening center. ... Read more

May 3, 2016May 4, 2016

FDA Approves COPD Treatment Bevespi Aerosphere, a Long-acting Dual Bronchodilator

Chronic Bronchitis, COPD, Emphysema, News

The U.S. FDA has approval AstraZeneca’s Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) for long-term maintenance treatment of airflow obstruction in patients suffering from chronic obstructive pulmonary disease (COPD), including emphysema and/or chronic bronchitis. ... Read more

May 3, 2016May 3, 2016

Cytori Updates Phase 3 Scleroderma STAR Trial, Enrolls 60th Patient

News, Scleroderma

Cell therapy company Cytori Therapeutics announced that its Phase 3 STAR clinical trial has enrolled and treated its 60th patient, reaching 75 percent of the target enrollment (80 patients). Safety data review ... Read more

May 2, 2016May 2, 2016

Cumberland Pharmaceuticals to Begin Development of Scleroderma Drug Vasculan

News, Scleroderma

Cumberland Pharmaceuticals recently added Vasculan to its clinical portfolio. The company has began the clinical development of Vasculan (ifetroban) oral capsule for the treatment of systemic sclerosis (SSc), also know ... Read more

May 2, 2016May 2, 2016

Pulmonary Hypertension Association Appoints New President and CEO

News, Pulmonary Hypertension

The Pulmonary Hypertension Association (PHA) has named a new president and chief executive officer, Brad A. Wong, of San Rafael, California. Wong will take on his new role June 19 at the ... Read more

May 2, 2016October 17, 2016

Phase 3 Clinical Trials for COPD Treatment Return Positive Results, Sunovion Reports

COPD, News

Sunovion Pharmaceuticals, a biopharma focused on the development of medical solutions for respiratory, neurological, and psychiatric conditions, recently announced positive results from the Phase 3 trial program assessing SUN-101 (glycopyrrolate) for ... Read more

April 29, 2016April 29, 2016

Lung Squamous Cell Carcinoma Phase 1/2 Trial to Assess Glembatumumab Vedotin Therapy

Lung Cancer, News

New Jersey-based Celldex Therapeutics recently announced the initiation of a Phase 1/2 clinical trial of glembatumumab vedotin in patients with squamous cell carcinoma. The study will focus on the safety and ... Read more

April 29, 2016April 29, 2016

Cystic Fibrosis Patient Receives Rare Dual Lung, Liver Transplant at UT Southwestern Hospital

Cystic Fibrosis, News

Josiah Ferrell, a 25-year-old patient with cystic fibrosis (CF), is successfully recovering from a dual lung and liver transplant. The rare procedure, performed by surgeons at the University of Texas ... Read more